Moving Medical Semeiotics to the Digital Realm - SEMEOTICONS Approach to Face Signs of Cardiometabolic Risk

Giuseppe Coppini, Riccardo Favilla, Amalia gastaldelli, Sara Colantonio, Paolo Marraccini

Abstract

In modern medicine signs derivable from face observation remain an important part of the physical examination that, together with the anamnesis, constitutes the basis for a rational decision-making. Therefore, face semiotics may be considered as a potential source of information for obtaining markers of obesity, metabolomics, cardiovascular homeostasis and psychophysical status. Once properly mapped to computational descriptors, their systematic exploitation is expected allowing the building of effective self-monitoring systems. In this perspective, in the frame of the FP7 project SEMEOTICONS, the most relevant face signs of cardio-metabolic risk are reviewed and analysed so as to drive their detection, quantification and integration into a virtual individual model useful for cardio-metabolic risk prevention.

References

  1. Aktas MK, Ozduran V, Pothier CE, Lang R, Lauer MS. 2004, Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA, 292:1462 - 1468.
  2. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med (2006) 23: 469-480.
  3. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR;, 2013.Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA, 289:2083-2093.
  4. Capewell S, O'Flaherty M, 2011. Rapid mortality falls after risk-factor changes in populations. Lancet, 378:752-753.
  5. Di Chiara A, Vanuzzo D. 2009. Does surveillance impact on cardiovascular prevention? Eur Heart J, 30:1027- 1029.
  6. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. 2007. Explaining the decrease in U.S. deaths from coronary disease, 1980 - 2000. N Engl J Med, 356:2388 - 2398.
  7. Graham I, Atar D, Borch-Johnsen K, et al. 2007. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil, 14 Suppl 2:1-113.
  8. Grundy SM et al. 2005. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation, 112:2735-2752.
  9. Honka A, Kaipainen K, Hietala H, Saranummi N, 2011. Rethinking Health: ICT-Enabled Services to Empower People to Manage Their Health. IEEE Reviews in Biomedical Engineering, 4:119-139.
  10. Ikawa T, Ishii K, Awazu K, 2009. Hyperspectral imaging of lipids using near-infrared super continuum light. WC 2009, IFMBE Proceedings 25/II: 630-632.
  11. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24:683- 689.
  12. Joyner MJ et al, 2001. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol, 91:1619-1626.
  13. Kahn R, Buse J, Ferrannin E, Stern M, 2005. The metabolic syndrome: Time for a critical appraisal. Diabetes Care, 28:2289-2304.
  14. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. , 2009. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16:121 - 137.
  15. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Reiner Z, Keil U. 2010. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil, 17:530 - 540.
  16. Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH, 2007. Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med. 12:13-6.
  17. Laaksonen DE, Lakka H-M, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA, 2002. Low Levels of LeisureTime Physical Activity and Cardiorespiratory Fitness Predict Development of the Metabolic Syndrome. Diabetes Care, 25(9): 1612-1618.
  18. Lorenzo CL, Williams K, Hunt KJ, Haffner SM, 2007. National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and WHO Definitions of the Metabolic Syndrome as Predictors of Cardiovascular Disease and Diabetes. Diabetes Care, 1:8-13.
  19. Mancini GJ, Chan S, Frohlich J, Kuramoto L, Sulzer M, Abbott D. 2002. Association of skin cholesterol content, measure by a novel non-invasive method, with markers of inflammation and Framingham risk prediction. Am J Cardiol, 89:1313-6.
  20. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ. 2004. Simple non-invasive assessment of advanced glycation endproducts accumulation. Diabetologia. 47:1324-30.
  21. National Cholesterol Education Program, 2002. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation, 106:3143-3421.
  22. National Institute for Health and Clinical Excellence, 2010 Prevention of Cardiovascular Disease: Costing Report. 2010. Nice Public Health Guidance 25.
  23. Pandya A, Gaziano TA, Weinstein MC, Cutler D, 2013. More Americans Living Longer With Cardiovascular Disease Will Increase Costs While Lowering Quality Of Life. Health Aff, 32:1706-1714.
  24. Peretz A, Leotta DF, Sullivan JH, Trenga CA, Sands FN, Aulet MR, Paun M, Gill EA, Kaufman JD, 2007. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovascular Disorders, 7:11.
  25. Singh R, Barden A, Mori T, Beilin L, 2001. Advanced glycation end-products: a review. Diabetologia, 44: 129-146.
  26. Tunstall-Pedoe H (World Health Organization). MONICA Monograph and Multimedia Sourcebook. 2003.
  27. Pantic, M, Bartlett M, 2007. Machine Analysis of Facial Expressions, Face Recognition. In: I-Tech Education and Publishing, Vienna, Austria, pp. 377-416.
  28. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, KeinanenKiukaanniemi S, Laakso M, Louheranta A, Rastas M, et al., 2001: Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med, 344(18):1343- 1350.
  29. Vale M, Jelinek M, Best J, 2005. Impact of coaching patients on coro- nary risk factors - Lessons from the COACH Program. Disease Management & Health Outcomes 13(4):225-244.
  30. Ward LM, Carl Heneghan C, Perera R, Dan Lasserson D, Nunan D, Mant D, Glasziou P, 2010. What are the basic self-monitoring components for cardiovascular risk management? BMC Medical Research, 10:105.
  31. Wing RR, Jeffery RW, 1999. Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance. J Consult Clin Psychol; 67:132-138.
  32. World Health Organization, 2008. The Global Burden of Disease: 2004 Update, Geneva, Switzerland: World Health Organization.
  33. Zawydiwski R, Sprecher DL, Evelegh MJ, Horse- wood P, Carte C, Patterson M. 2001. A novel test for the measurement of skin cholesterol. Clin Chem, 47: 1302-1304.
Download


Paper Citation


in Harvard Style

Coppini G., Favilla R., gastaldelli A., Colantonio S. and Marraccini P. (2014). Moving Medical Semeiotics to the Digital Realm - SEMEOTICONS Approach to Face Signs of Cardiometabolic Risk . In Proceedings of the International Conference on Health Informatics - Volume 1: SUPERHEAL, (BIOSTEC 2014) ISBN 978-989-758-010-9, pages 606-613. DOI: 10.5220/0004939106060613


in Bibtex Style

@conference{superheal14,
author={Giuseppe Coppini and Riccardo Favilla and Amalia gastaldelli and Sara Colantonio and Paolo Marraccini},
title={Moving Medical Semeiotics to the Digital Realm - SEMEOTICONS Approach to Face Signs of Cardiometabolic Risk},
booktitle={Proceedings of the International Conference on Health Informatics - Volume 1: SUPERHEAL, (BIOSTEC 2014)},
year={2014},
pages={606-613},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0004939106060613},
isbn={978-989-758-010-9},
}


in EndNote Style

TY - CONF
JO - Proceedings of the International Conference on Health Informatics - Volume 1: SUPERHEAL, (BIOSTEC 2014)
TI - Moving Medical Semeiotics to the Digital Realm - SEMEOTICONS Approach to Face Signs of Cardiometabolic Risk
SN - 978-989-758-010-9
AU - Coppini G.
AU - Favilla R.
AU - gastaldelli A.
AU - Colantonio S.
AU - Marraccini P.
PY - 2014
SP - 606
EP - 613
DO - 10.5220/0004939106060613